THE DIvO STUDY
Digital Imaging versus Ophthalmoscopy for congenital cataract screening
Cataracts don't only affect older people ...
Did you know that cataract is the commonest cause of avoidable child blindness in the world?

The DIvO (Digital Imaging versus Ophthalmoscopy) study is a three year UK clinical study which aims to find out if digital imaging is a more accurate method of detecting cataracts in newborn babies than the current technique using an ophthalmoscope (a medical eye torch).

Each baby taking part in the study will have both the standard ophthalmoscopy test and imaging with the study device so that we can compare to see if either is more accurate. Only around 3 in 10,000 babies are born with cataract, so we need 140,000 babies to take part in the study to be sure of the result.

​ ​​Find out more about baby cataract here.     Find out more about newborn eye screening here.
WHEN AND WHERE IS THE STUDY TAKING PLACE?

The study is currently in its initial stages and is expected to be under way by the summer of 2021 in 15 UK NHS maternity hospitals. If you are due to have your baby between summer 2021 and 2024 you may be asked for your permission to enrol your baby in the study.

Click here to see the maternity centres taking part in the study.

Interested in taking part?  Find out what this would mean for you and your baby here.
​​WHAT THIS COULD THIS MEAN FOR THE FUTURE ..

Improved cataract detection, resulting in earlier surgery, could reduce the risk of life-long visual impairment in babies born with cataract. The findings of this study may result in a change to national newborn eye screening policy.

The anonymised eye images collected from this study could also be used to develop and train software which would automatically alert the midwife when it recognised a potential problem. This would mean that an accurate means of infant and childhood eye screening could become available in rural communities across the world, where trained healthcare staff are often not available.
The DIvO study has been funded by a grant from the National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) programme.